OtoRhinoLaryngology by Sfakianakis G.Alexandros Sfakianakis G.Alexandros,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,tel : 00302841026182,00306932607174
Τετάρτη 3 Φεβρουαρίου 2016
Speech recognition in noise under hearing protection: A computational study of the combined effects of hearing loss and hearing protector attenuation
from #Audiology via ola Kala on Inoreader http://ift.tt/1R205Pr
via IFTTT
Celebrating hearing loss prevention
from #Audiology via ola Kala on Inoreader http://ift.tt/1R205yY
via IFTTT
Auditory risk of air rifles
from #Audiology via ola Kala on Inoreader http://ift.tt/1UK4tBK
via IFTTT
Speech recognition in noise under hearing protection: A computational study of the combined effects of hearing loss and hearing protector attenuation
from #Audiology via ola Kala on Inoreader http://ift.tt/1R205Pr
via IFTTT
Celebrating hearing loss prevention
from #Audiology via ola Kala on Inoreader http://ift.tt/1R205yY
via IFTTT
Auditory risk of air rifles
from #Audiology via ola Kala on Inoreader http://ift.tt/1KpV2qs
via IFTTT
Speech recognition in noise under hearing protection: A computational study of the combined effects of hearing loss and hearing protector attenuation
from #Audiology via ola Kala on Inoreader http://ift.tt/1KpV41L
via IFTTT
Celebrating hearing loss prevention
from #Audiology via ola Kala on Inoreader http://ift.tt/1md61bi
via IFTTT
Auditory risk of air rifles
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1KpV2qs
via IFTTT
Speech recognition in noise under hearing protection: A computational study of the combined effects of hearing loss and hearing protector attenuation
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1KpV41L
via IFTTT
Celebrating hearing loss prevention
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1md61bi
via IFTTT
Auditory risk of air rifles
from #Audiology via ola Kala on Inoreader http://ift.tt/1KpV2qs
via IFTTT
Speech recognition in noise under hearing protection: A computational study of the combined effects of hearing loss and hearing protector attenuation
from #Audiology via ola Kala on Inoreader http://ift.tt/1KpV41L
via IFTTT
Celebrating hearing loss prevention
from #Audiology via ola Kala on Inoreader http://ift.tt/1md61bi
via IFTTT
Danish reading span data from 283 hearing-aid users, including a sub-group analysis of their relationship to speech-in-noise performance.
Related Articles |
Danish reading span data from 283 hearing-aid users, including a sub-group analysis of their relationship to speech-in-noise performance.
Int J Audiol. 2016 Feb 2;:1-8
Authors: Borch Petersen E, Lunner T, Vestergaard MD, Sundewall Thorén E
Abstract
OBJECTIVE: This study provides descriptive statistics of the Danish reading span (RS) test for hearing-impaired adults. The combined effect of hearing loss, RS score, and age on speech-in-noise performance in different spatial settings was evaluated in a subset of participants.
DESIGN: Data from published and unpublished studies were re-analysed. Data regarding speech-in-noise performance with co-located or spatially separated sound sources were available for a subset of participants.
STUDY SAMPLE: RS scores from 283 hearing-impaired participants were extracted from past studies, and 239 of these participants had completed a speech-in-noise test.
RESULTS: RS scores (mean = 41.91%, standard deviation = 11.29%) were related to age (p <0.01), but not pure-tone average (PTA) (p = 0.29). Speech-in-noise performance for co-located sound sources was related to PTA and RS score (both p < 0.01, adjusted R-squared = 0.226). Performance for spatially separated sounds was related to PTA (p < 0.01, adjusted R-squared = 0.10) but not RS score (p = 0.484). We found no differences between the standardized coefficients of the two regression models.
CONCLUSIONS: The distribution of RS scores indicated a high test difficulty. We found that age should be controlled when RS scores are compared across populations. The experimental setup of the speech-in-noise test may influence the relationship between performance and RS score.
PMID: 26836955 [PubMed - as supplied by publisher]
from #Audiology via ola Kala on Inoreader http://ift.tt/1mcOyA1
via IFTTT
Danish reading span data from 283 hearing-aid users, including a sub-group analysis of their relationship to speech-in-noise performance.
Related Articles |
Danish reading span data from 283 hearing-aid users, including a sub-group analysis of their relationship to speech-in-noise performance.
Int J Audiol. 2016 Feb 2;:1-8
Authors: Borch Petersen E, Lunner T, Vestergaard MD, Sundewall Thorén E
Abstract
OBJECTIVE: This study provides descriptive statistics of the Danish reading span (RS) test for hearing-impaired adults. The combined effect of hearing loss, RS score, and age on speech-in-noise performance in different spatial settings was evaluated in a subset of participants.
DESIGN: Data from published and unpublished studies were re-analysed. Data regarding speech-in-noise performance with co-located or spatially separated sound sources were available for a subset of participants.
STUDY SAMPLE: RS scores from 283 hearing-impaired participants were extracted from past studies, and 239 of these participants had completed a speech-in-noise test.
RESULTS: RS scores (mean = 41.91%, standard deviation = 11.29%) were related to age (p <0.01), but not pure-tone average (PTA) (p = 0.29). Speech-in-noise performance for co-located sound sources was related to PTA and RS score (both p < 0.01, adjusted R-squared = 0.226). Performance for spatially separated sounds was related to PTA (p < 0.01, adjusted R-squared = 0.10) but not RS score (p = 0.484). We found no differences between the standardized coefficients of the two regression models.
CONCLUSIONS: The distribution of RS scores indicated a high test difficulty. We found that age should be controlled when RS scores are compared across populations. The experimental setup of the speech-in-noise test may influence the relationship between performance and RS score.
PMID: 26836955 [PubMed - as supplied by publisher]
from #Audiology via ola Kala on Inoreader http://ift.tt/1mcOyA1
via IFTTT
Clinical Practice Guideline: Otitis Media with Effusion (Update).
Related Articles |
Clinical Practice Guideline: Otitis Media with Effusion (Update).
Otolaryngol Head Neck Surg. 2016 Feb;154(1 Suppl):S1-S41
Authors: Rosenfeld RM, Shin JJ, Schwartz SR, Coggins R, Gagnon L, Hackell JM, Hoelting D, Hunter LL, Kummer AW, Payne SC, Poe DS, Veling M, Vila PM, Walsh SA, Corrigan MD
Abstract
OBJECTIVE: This update of a 2004 guideline codeveloped by the American Academy of Otolaryngology-Head and Neck Surgery Foundation, the American Academy of Pediatrics, and the American Academy of Family Physicians, provides evidence-based recommendations to manage otitis media with effusion (OME), defined as the presence of fluid in the middle ear without signs or symptoms of acute ear infection. Changes from the prior guideline include consumer advocates added to the update group, evidence from 4 new clinical practice guidelines, 20 new systematic reviews, and 49 randomized control trials, enhanced emphasis on patient education and shared decision making, a new algorithm to clarify action statement relationships, and new and expanded recommendations for the diagnosis and management of OME.
PURPOSE: The purpose of this multidisciplinary guideline is to identify quality improvement opportunities in managing OME and to create explicit and actionable recommendations to implement these opportunities in clinical practice. Specifically, the goals are to improve diagnostic accuracy, identify children who are most susceptible to developmental sequelae from OME, and educate clinicians and patients regarding the favorable natural history of most OME and the clinical benefits for medical therapy (eg, steroids, antihistamines, decongestants). Additional goals relate to OME surveillance, hearing and language evaluation, and management of OME detected by newborn screening. The target patient for the guideline is a child aged 2 months through 12 years with OME, with or without developmental disabilities or underlying conditions that predispose to OME and its sequelae. The guideline is intended for all clinicians who are likely to diagnose and manage children with OME, and it applies to any setting in which OME would be identified, monitored, or managed. This guideline, however, does not apply to patients <2 months or >12 years old.
ACTION STATEMENTS: The update group made strong recommendations that clinicians (1) should document the presence of middle ear effusion with pneumatic otoscopy when diagnosing OME in a child; (2) should perform pneumatic otoscopy to assess for OME in a child with otalgia, hearing loss, or both; (3) should obtain tympanometry in children with suspected OME for whom the diagnosis is uncertain after performing (or attempting) pneumatic otoscopy; (4) should manage the child with OME who is not at risk with watchful waiting for 3 months from the date of effusion onset (if known) or 3 months from the date of diagnosis (if onset is unknown); (5) should recommend against using intranasal or systemic steroids for treating OME; (6) should recommend against using systemic antibiotics for treating OME; and (7) should recommend against using antihistamines, decongestants, or both for treating OME.The update group made recommendations that clinicians (1) should document in the medical record counseling of parents of infants with OME who fail a newborn screening regarding the importance of follow-up to ensure that hearing is normal when OME resolves and to exclude an underlying sensorineural hearing loss; (2) should determine if a child with OME is at increased risk for speech, language, or learning problems from middle ear effusion because of baseline sensory, physical, cognitive, or behavioral factors; (3) should evaluate at-risk children for OME at the time of diagnosis of an at-risk condition and at 12 to 18 months of age (if diagnosed as being at risk prior to this time); (4) should not routinely screen children for OME who are not at risk and do not have symptoms that may be attributable to OME, such as hearing difficulties, balance (vestibular) problems, poor school performance, behavioral problems, or ear discomfort; (5) should educate children with OME and their families regarding the natural history of OME, need for follow-up, and the possible sequelae; (6) should obtain an age-appropriate hearing test if OME persists for 3 months or longer OR for OME of any duration in an at-risk child; (7) should counsel families of children with bilateral OME and documented hearing loss about the potential impact on speech and language development; (8) should reevaluate, at 3- to 6-month intervals, children with chronic OME until the effusion is no longer present, significant hearing loss is identified, or structural abnormalities of the eardrum or middle ear are suspected; (9) should recommend tympanostomy tubes when surgery is performed for OME in a child <4 years old; adenoidectomy should not be performed unless a distinct indication exists (nasal obstruction, chronic adenoiditis); (10) should recommend tympanostomy tubes, adenoidectomy, or both when surgery is performed for OME in a child ≥4 years old; and (11) should document resolution of OME, improved hearing, or improved quality of life when managing a child with OME.
PMID: 26832942 [PubMed - in process]
from #Audiology via xlomafota13 on Inoreader http://ift.tt/20pFdaJ
via IFTTT
Histone deacetylase 1 is required for the development of the zebrafish inner ear.
Related Articles |
Histone deacetylase 1 is required for the development of the zebrafish inner ear.
Sci Rep. 2016;6:16535
Authors: He Y, Tang D, Li W, Chai R, Li H
Abstract
Histone deacetylase 1 (HDAC1) has been reported to be important for multiple aspects of normal embryonic development, but little is known about its function in the development of mechanosensory organs. Here, we first confirmed that HDAC1 is expressed in the developing otic vesicles of zebrafish by whole-mount in situ hybridization. Knockdown of HDAC1 using antisense morpholino oligonucleotides in zebrafish embryos induced smaller otic vesicles, abnormal otoliths, malformed or absent semicircular canals, and fewer sensory hair cells. HDAC1 loss of function also caused attenuated expression of a subset of key genes required for otic vesicle formation during development. Morpholino-mediated knockdown of HDAC1 resulted in decreased expression of members of the Fgf family in the otic vesicles, suggesting that HDAC1 is involved in the development of the inner ear through regulation of Fgf signaling pathways. Taken together, our results indicate that HDAC1 plays an important role in otic vesicle formation.
PMID: 26832938 [PubMed - in process]
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1JXWsbS
via IFTTT
Phenotypic Heterogeneity in a DFNA20/26 family segregating a novel ACTG1 mutation.
Related Articles |
Phenotypic Heterogeneity in a DFNA20/26 family segregating a novel ACTG1 mutation.
BMC Genet. 2016;17(1):33
Authors: Yuan Y, Gao X, Huang B, Lu J, Wang G, Lin X, Qu Y, Dai P
Abstract
BACKGROUND: Genetic factors play an important role in hearing loss, contributing to approximately 60 % of cases of congenital hearing loss. Autosomal dominant deafness accounts for approximately 20 % of cases of hereditary hearing loss. Diseases with autosomal dominant inheritance often show pleiotropy, different degrees of penetrance, and variable expressivity.
METHODS: A three-generation Chinese family with autosomal dominant nonsyndromic hearing impairment (ADNSHI) was enrolled in this study. Audiometric data and blood samples were collected from the family. In total, 129 known human deafness genes were sequenced using next-generation sequencing (NGS) to identify the responsible gene mutation in the family. Whole Exome Sequencing (WES) was performed to exclude any other variant that cosegregated with the phenotype.
RESULTS: The age of onset of the affected family members was the second decade of life. The condition began with high-frequency hearing impairment in all family members excluding III:2. The novel ACTG1 c.638A > G (p.K213R) mutation was found in all affected family members and was not found in the unaffected family members. A heterozygous c.638A > G mutation in ACTG1 and homozygous c.109G > A (p.V37I) mutation in GJB2 were found in III:2, who was born with hearing loss. The WES result concurred with that of targeted sequencing of known deafness genes.
CONCLUSIONS: The novel mutation p.K213R in ACTG1 was found to be co-segregated with hearing loss and the genetic cause of ADNSHI in this family. A homozygous mutation associated with recessive inheritance only rarely co-acts with a dominant mutation to result in hearing loss in a dominant family. In such cases, the mutations in the two genes, as in ACTG1 and GJB2 in the present study, may result in a more severe phenotype. Targeted sequencing of known deafness genes is one of the best choices to identify the genetic cause in hereditary hearing loss families.
PMID: 26832775 [PubMed - in process]
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1JXWsbQ
via IFTTT
Care of Adults With Intellectual and Developmental Disabilities: Down Syndrome.
Related Articles |
Care of Adults With Intellectual and Developmental Disabilities: Down Syndrome.
FP Essent. 2015 Dec;439:20-5
Authors: Wilson B, Jones KB, Weedon D, Bilder D
Abstract
Down syndrome (DS) is a genetic disorder involving excess genetic material from chromosome 21. The incidence of DS is increasing, and the life expectancy for individuals with DS has increased to a median age of 55 years. Adults with DS are at increased risk of several conditions, including significant neurologic, cardiovascular, pulmonary, gastrointestinal, musculoskeletal, endocrine, psychiatric, hematologic, and social comorbidities, and additional screening or monitoring may be needed. Additional preventive measures for patients with DS include regular screening for thyroid dysfunction, hearing loss, eye disorders, heart disease, osteoporosis, and dementia, and one-time vaccination with the polyvalent pneumococcal polysaccharide vaccine (PPV23). Quality of life should be the main focus of treatment, with patients being involved in medical decisions as much as possible.
PMID: 26669211 [PubMed - indexed for MEDLINE]
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1JXWq3O
via IFTTT
A Founder Mutation in MYO7A Underlies a Significant Proportion of Usher Syndrome in Indigenous South Africans: Implications for the African Diaspora.
Related Articles |
A Founder Mutation in MYO7A Underlies a Significant Proportion of Usher Syndrome in Indigenous South Africans: Implications for the African Diaspora.
Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6671-8
Authors: Roberts L, George S, Greenberg J, Ramesar RS
Abstract
PURPOSE: Research over the past 25 years at the University of Cape Town has led to the identification of causative mutations in 17% of the 1416 families in the Retinal Degenerative Diseases (RDD) biorepository in South Africa. A low rate of mutation detection has been observed in patients of indigenous African origin, hinting at novel genes and mutations in this population. Recently, however, data from our translational research program showed two unrelated indigenous African families with Usher syndrome (USH), with the same homozygous MYO7A mutation. Therefore, the extent to which this mutation contributes toward the disease burden in South Africa was investigated.
METHODS: Cohorts of unrelated indigenous South African probands with different RDD diagnoses were tested for the MYO7A c.6377delC mutation. Familial cosegregation analysis was performed for homozygous probands, clinical data were evaluated, and SNP haplotypes were analyzed.
RESULTS: This homozygous MYO7A mutation underlies a remarkable 43% of indigenous African USH cases investigated in this study, the majority of which (60%) were diagnosed clinically with Type 2 USH. All homozygotes shared a common haplotype. This mutation does not appear to cause nonsyndromic vision loss.
CONCLUSIONS: Of interest is the origin of this common mutation relevant to the Bantu population migration into southern Africa. Further investigation of the phenotype may elucidate the disease biology, and perhaps reveal a larger cohort with the same mutation, with which to assess the impact of environmental and genetic modifiers and evaluate therapeutic trials.
PMID: 26469752 [PubMed - indexed for MEDLINE]
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1SG6Vdi
via IFTTT
Danish reading span data from 283 hearing-aid users, including a sub-group analysis of their relationship to speech-in-noise performance.
Related Articles |
Danish reading span data from 283 hearing-aid users, including a sub-group analysis of their relationship to speech-in-noise performance.
Int J Audiol. 2016 Feb 2;:1-8
Authors: Borch Petersen E, Lunner T, Vestergaard MD, Sundewall Thorén E
Abstract
OBJECTIVE: This study provides descriptive statistics of the Danish reading span (RS) test for hearing-impaired adults. The combined effect of hearing loss, RS score, and age on speech-in-noise performance in different spatial settings was evaluated in a subset of participants.
DESIGN: Data from published and unpublished studies were re-analysed. Data regarding speech-in-noise performance with co-located or spatially separated sound sources were available for a subset of participants.
STUDY SAMPLE: RS scores from 283 hearing-impaired participants were extracted from past studies, and 239 of these participants had completed a speech-in-noise test.
RESULTS: RS scores (mean = 41.91%, standard deviation = 11.29%) were related to age (p <0.01), but not pure-tone average (PTA) (p = 0.29). Speech-in-noise performance for co-located sound sources was related to PTA and RS score (both p < 0.01, adjusted R-squared = 0.226). Performance for spatially separated sounds was related to PTA (p < 0.01, adjusted R-squared = 0.10) but not RS score (p = 0.484). We found no differences between the standardized coefficients of the two regression models.
CONCLUSIONS: The distribution of RS scores indicated a high test difficulty. We found that age should be controlled when RS scores are compared across populations. The experimental setup of the speech-in-noise test may influence the relationship between performance and RS score.
PMID: 26836955 [PubMed - as supplied by publisher]
from #Audiology via ola Kala on Inoreader http://ift.tt/1mcOyA1
via IFTTT
Danish reading span data from 283 hearing-aid users, including a sub-group analysis of their relationship to speech-in-noise performance.
Related Articles |
Danish reading span data from 283 hearing-aid users, including a sub-group analysis of their relationship to speech-in-noise performance.
Int J Audiol. 2016 Feb 2;:1-8
Authors: Borch Petersen E, Lunner T, Vestergaard MD, Sundewall Thorén E
Abstract
OBJECTIVE: This study provides descriptive statistics of the Danish reading span (RS) test for hearing-impaired adults. The combined effect of hearing loss, RS score, and age on speech-in-noise performance in different spatial settings was evaluated in a subset of participants.
DESIGN: Data from published and unpublished studies were re-analysed. Data regarding speech-in-noise performance with co-located or spatially separated sound sources were available for a subset of participants.
STUDY SAMPLE: RS scores from 283 hearing-impaired participants were extracted from past studies, and 239 of these participants had completed a speech-in-noise test.
RESULTS: RS scores (mean = 41.91%, standard deviation = 11.29%) were related to age (p <0.01), but not pure-tone average (PTA) (p = 0.29). Speech-in-noise performance for co-located sound sources was related to PTA and RS score (both p < 0.01, adjusted R-squared = 0.226). Performance for spatially separated sounds was related to PTA (p < 0.01, adjusted R-squared = 0.10) but not RS score (p = 0.484). We found no differences between the standardized coefficients of the two regression models.
CONCLUSIONS: The distribution of RS scores indicated a high test difficulty. We found that age should be controlled when RS scores are compared across populations. The experimental setup of the speech-in-noise test may influence the relationship between performance and RS score.
PMID: 26836955 [PubMed - as supplied by publisher]
from #Audiology via ola Kala on Inoreader http://ift.tt/1mcOyA1
via IFTTT
Clinical Practice Guideline: Otitis Media with Effusion (Update).
Related Articles |
Clinical Practice Guideline: Otitis Media with Effusion (Update).
Otolaryngol Head Neck Surg. 2016 Feb;154(1 Suppl):S1-S41
Authors: Rosenfeld RM, Shin JJ, Schwartz SR, Coggins R, Gagnon L, Hackell JM, Hoelting D, Hunter LL, Kummer AW, Payne SC, Poe DS, Veling M, Vila PM, Walsh SA, Corrigan MD
Abstract
OBJECTIVE: This update of a 2004 guideline codeveloped by the American Academy of Otolaryngology-Head and Neck Surgery Foundation, the American Academy of Pediatrics, and the American Academy of Family Physicians, provides evidence-based recommendations to manage otitis media with effusion (OME), defined as the presence of fluid in the middle ear without signs or symptoms of acute ear infection. Changes from the prior guideline include consumer advocates added to the update group, evidence from 4 new clinical practice guidelines, 20 new systematic reviews, and 49 randomized control trials, enhanced emphasis on patient education and shared decision making, a new algorithm to clarify action statement relationships, and new and expanded recommendations for the diagnosis and management of OME.
PURPOSE: The purpose of this multidisciplinary guideline is to identify quality improvement opportunities in managing OME and to create explicit and actionable recommendations to implement these opportunities in clinical practice. Specifically, the goals are to improve diagnostic accuracy, identify children who are most susceptible to developmental sequelae from OME, and educate clinicians and patients regarding the favorable natural history of most OME and the clinical benefits for medical therapy (eg, steroids, antihistamines, decongestants). Additional goals relate to OME surveillance, hearing and language evaluation, and management of OME detected by newborn screening. The target patient for the guideline is a child aged 2 months through 12 years with OME, with or without developmental disabilities or underlying conditions that predispose to OME and its sequelae. The guideline is intended for all clinicians who are likely to diagnose and manage children with OME, and it applies to any setting in which OME would be identified, monitored, or managed. This guideline, however, does not apply to patients <2 months or >12 years old.
ACTION STATEMENTS: The update group made strong recommendations that clinicians (1) should document the presence of middle ear effusion with pneumatic otoscopy when diagnosing OME in a child; (2) should perform pneumatic otoscopy to assess for OME in a child with otalgia, hearing loss, or both; (3) should obtain tympanometry in children with suspected OME for whom the diagnosis is uncertain after performing (or attempting) pneumatic otoscopy; (4) should manage the child with OME who is not at risk with watchful waiting for 3 months from the date of effusion onset (if known) or 3 months from the date of diagnosis (if onset is unknown); (5) should recommend against using intranasal or systemic steroids for treating OME; (6) should recommend against using systemic antibiotics for treating OME; and (7) should recommend against using antihistamines, decongestants, or both for treating OME.The update group made recommendations that clinicians (1) should document in the medical record counseling of parents of infants with OME who fail a newborn screening regarding the importance of follow-up to ensure that hearing is normal when OME resolves and to exclude an underlying sensorineural hearing loss; (2) should determine if a child with OME is at increased risk for speech, language, or learning problems from middle ear effusion because of baseline sensory, physical, cognitive, or behavioral factors; (3) should evaluate at-risk children for OME at the time of diagnosis of an at-risk condition and at 12 to 18 months of age (if diagnosed as being at risk prior to this time); (4) should not routinely screen children for OME who are not at risk and do not have symptoms that may be attributable to OME, such as hearing difficulties, balance (vestibular) problems, poor school performance, behavioral problems, or ear discomfort; (5) should educate children with OME and their families regarding the natural history of OME, need for follow-up, and the possible sequelae; (6) should obtain an age-appropriate hearing test if OME persists for 3 months or longer OR for OME of any duration in an at-risk child; (7) should counsel families of children with bilateral OME and documented hearing loss about the potential impact on speech and language development; (8) should reevaluate, at 3- to 6-month intervals, children with chronic OME until the effusion is no longer present, significant hearing loss is identified, or structural abnormalities of the eardrum or middle ear are suspected; (9) should recommend tympanostomy tubes when surgery is performed for OME in a child <4 years old; adenoidectomy should not be performed unless a distinct indication exists (nasal obstruction, chronic adenoiditis); (10) should recommend tympanostomy tubes, adenoidectomy, or both when surgery is performed for OME in a child ≥4 years old; and (11) should document resolution of OME, improved hearing, or improved quality of life when managing a child with OME.
PMID: 26832942 [PubMed - in process]
from #Audiology via ola Kala on Inoreader http://ift.tt/20pFdaJ
via IFTTT
Toxicity of silver nanoparticle in rat ear and BALB/c 3T3 cell line.
Related Articles |
Toxicity of silver nanoparticle in rat ear and BALB/c 3T3 cell line.
J Nanobiotechnology. 2014;12:52
Authors: Zou J, Feng H, Mannerström M, Heinonen T, Pyykkö I
Abstract
BACKGROUND: Silver nanoparticles (AgNPs) displayed strong activities in anti-bacterial, anti-viral, and anti-fungal studies and was reportedly efficient in treating otitis media .The potential impact of AgNPs on the inner ear was missing.
OBJECTIVE: Attempted to evaluate the potential toxicity of AgNPs in the inner ear, middle ear, and external ear canal after transtympanic injection in rats.
RESULTS: In in vitro studies, the IC50 for AgNPs in neutral red uptake assay was lower than that in NAD(P)H-dependent cellular oxidoreductase enzyme assay (WST-1) and higher than that in total cellular ATP and nuclear membrane integrity (propidium iodide) assessments. In in vivo experiments, magnetic resonance imaging (MRI) showed that significant changes in the permeability of biological barriers occurred in the middle ear mucosa, the skin of the external ear canal, and the inner ear at 5 h post-transtympanic injection of AgNPs at concentrations ranging from 20 μg/ml to 4000 μg/ml. The alterations in permeability showed a dosage-response relationship, and were reversible. The auditory brainstem response showed that 4000 μg/ml AgNPs induced hearing loss with partial recovery at 7 d, whereas 20 μg/ml caused reversible hearing loss. The functional change in auditory system was in line with the histology results. In general, the BALB/c 3T3 cell line is more than 1000 times more sensitive than the in vivo studies. Impairment of the mitochondrial function was indicated to be the mechanism of toxicity of AgNPs.
CONCLUSION: These results suggest that AgNPs caused significant, dose-dependent changes in the permeability of biological barriers in the middle ear mucosa, the skin of the external ear canal, and the inner ear. In general, the BALB/c 3T3 cell line is more than 1000 times more sensitive than the in vivo studies. The rat ear model might be expended to other engineered nanomaterials in nanotoxicology study.
PMID: 25467963 [PubMed - indexed for MEDLINE]
from #Audiology via ola Kala on Inoreader http://ift.tt/1mcMCHE
via IFTTT
Clinical Practice Guideline: Otitis Media with Effusion (Update).
Related Articles |
Clinical Practice Guideline: Otitis Media with Effusion (Update).
Otolaryngol Head Neck Surg. 2016 Feb;154(1 Suppl):S1-S41
Authors: Rosenfeld RM, Shin JJ, Schwartz SR, Coggins R, Gagnon L, Hackell JM, Hoelting D, Hunter LL, Kummer AW, Payne SC, Poe DS, Veling M, Vila PM, Walsh SA, Corrigan MD
Abstract
OBJECTIVE: This update of a 2004 guideline codeveloped by the American Academy of Otolaryngology-Head and Neck Surgery Foundation, the American Academy of Pediatrics, and the American Academy of Family Physicians, provides evidence-based recommendations to manage otitis media with effusion (OME), defined as the presence of fluid in the middle ear without signs or symptoms of acute ear infection. Changes from the prior guideline include consumer advocates added to the update group, evidence from 4 new clinical practice guidelines, 20 new systematic reviews, and 49 randomized control trials, enhanced emphasis on patient education and shared decision making, a new algorithm to clarify action statement relationships, and new and expanded recommendations for the diagnosis and management of OME.
PURPOSE: The purpose of this multidisciplinary guideline is to identify quality improvement opportunities in managing OME and to create explicit and actionable recommendations to implement these opportunities in clinical practice. Specifically, the goals are to improve diagnostic accuracy, identify children who are most susceptible to developmental sequelae from OME, and educate clinicians and patients regarding the favorable natural history of most OME and the clinical benefits for medical therapy (eg, steroids, antihistamines, decongestants). Additional goals relate to OME surveillance, hearing and language evaluation, and management of OME detected by newborn screening. The target patient for the guideline is a child aged 2 months through 12 years with OME, with or without developmental disabilities or underlying conditions that predispose to OME and its sequelae. The guideline is intended for all clinicians who are likely to diagnose and manage children with OME, and it applies to any setting in which OME would be identified, monitored, or managed. This guideline, however, does not apply to patients <2 months or >12 years old.
ACTION STATEMENTS: The update group made strong recommendations that clinicians (1) should document the presence of middle ear effusion with pneumatic otoscopy when diagnosing OME in a child; (2) should perform pneumatic otoscopy to assess for OME in a child with otalgia, hearing loss, or both; (3) should obtain tympanometry in children with suspected OME for whom the diagnosis is uncertain after performing (or attempting) pneumatic otoscopy; (4) should manage the child with OME who is not at risk with watchful waiting for 3 months from the date of effusion onset (if known) or 3 months from the date of diagnosis (if onset is unknown); (5) should recommend against using intranasal or systemic steroids for treating OME; (6) should recommend against using systemic antibiotics for treating OME; and (7) should recommend against using antihistamines, decongestants, or both for treating OME.The update group made recommendations that clinicians (1) should document in the medical record counseling of parents of infants with OME who fail a newborn screening regarding the importance of follow-up to ensure that hearing is normal when OME resolves and to exclude an underlying sensorineural hearing loss; (2) should determine if a child with OME is at increased risk for speech, language, or learning problems from middle ear effusion because of baseline sensory, physical, cognitive, or behavioral factors; (3) should evaluate at-risk children for OME at the time of diagnosis of an at-risk condition and at 12 to 18 months of age (if diagnosed as being at risk prior to this time); (4) should not routinely screen children for OME who are not at risk and do not have symptoms that may be attributable to OME, such as hearing difficulties, balance (vestibular) problems, poor school performance, behavioral problems, or ear discomfort; (5) should educate children with OME and their families regarding the natural history of OME, need for follow-up, and the possible sequelae; (6) should obtain an age-appropriate hearing test if OME persists for 3 months or longer OR for OME of any duration in an at-risk child; (7) should counsel families of children with bilateral OME and documented hearing loss about the potential impact on speech and language development; (8) should reevaluate, at 3- to 6-month intervals, children with chronic OME until the effusion is no longer present, significant hearing loss is identified, or structural abnormalities of the eardrum or middle ear are suspected; (9) should recommend tympanostomy tubes when surgery is performed for OME in a child <4 years old; adenoidectomy should not be performed unless a distinct indication exists (nasal obstruction, chronic adenoiditis); (10) should recommend tympanostomy tubes, adenoidectomy, or both when surgery is performed for OME in a child ≥4 years old; and (11) should document resolution of OME, improved hearing, or improved quality of life when managing a child with OME.
PMID: 26832942 [PubMed - in process]
from #Audiology via ola Kala on Inoreader http://ift.tt/20pFdaJ
via IFTTT
Toxicity of silver nanoparticle in rat ear and BALB/c 3T3 cell line.
Related Articles |
Toxicity of silver nanoparticle in rat ear and BALB/c 3T3 cell line.
J Nanobiotechnology. 2014;12:52
Authors: Zou J, Feng H, Mannerström M, Heinonen T, Pyykkö I
Abstract
BACKGROUND: Silver nanoparticles (AgNPs) displayed strong activities in anti-bacterial, anti-viral, and anti-fungal studies and was reportedly efficient in treating otitis media .The potential impact of AgNPs on the inner ear was missing.
OBJECTIVE: Attempted to evaluate the potential toxicity of AgNPs in the inner ear, middle ear, and external ear canal after transtympanic injection in rats.
RESULTS: In in vitro studies, the IC50 for AgNPs in neutral red uptake assay was lower than that in NAD(P)H-dependent cellular oxidoreductase enzyme assay (WST-1) and higher than that in total cellular ATP and nuclear membrane integrity (propidium iodide) assessments. In in vivo experiments, magnetic resonance imaging (MRI) showed that significant changes in the permeability of biological barriers occurred in the middle ear mucosa, the skin of the external ear canal, and the inner ear at 5 h post-transtympanic injection of AgNPs at concentrations ranging from 20 μg/ml to 4000 μg/ml. The alterations in permeability showed a dosage-response relationship, and were reversible. The auditory brainstem response showed that 4000 μg/ml AgNPs induced hearing loss with partial recovery at 7 d, whereas 20 μg/ml caused reversible hearing loss. The functional change in auditory system was in line with the histology results. In general, the BALB/c 3T3 cell line is more than 1000 times more sensitive than the in vivo studies. Impairment of the mitochondrial function was indicated to be the mechanism of toxicity of AgNPs.
CONCLUSION: These results suggest that AgNPs caused significant, dose-dependent changes in the permeability of biological barriers in the middle ear mucosa, the skin of the external ear canal, and the inner ear. In general, the BALB/c 3T3 cell line is more than 1000 times more sensitive than the in vivo studies. The rat ear model might be expended to other engineered nanomaterials in nanotoxicology study.
PMID: 25467963 [PubMed - indexed for MEDLINE]
from #Audiology via ola Kala on Inoreader http://ift.tt/1mcMCHE
via IFTTT
Immediate and One Week Effects of Laterally Wedge Insoles on Gait Biomechanics in Healthy Females
Source:Gait & Posture
Author(s): Joshua T. Weinhandl, Sarah E. Sudheimer, Bonnie L. Van Lunen, Kimberly Stewart, Matthew C. Hoch
It is estimated that approximately 45% of the U.S. population will develop knee osteoarthritis, a disease that creates significant economic burdens in both direct and indirect costs. Laterally wedged insoles have been frequently recommended to reduce knee abduction moments and to manage knee osteoarthritis. However, it remains unknown whether the lateral wedge will reduce knee abduction moments over a prolonged period of time. Thus, the purposes of this study were to 1) examine the immediate effects of a laterally wedged insole in individuals normally aligned knees and 2) determine prolonged effects after the insole was worn for one week. Gait analysis was performed on ten women with and without a laterally wedged insole. After participants wore the wedges for a week, a second gait analysis was performed with and without the insole. The wedged insole did not affect peak knee abduction moment, although there was a significant increase in knee abduction angular impulse after wearing the insoles for one week. Furthermore, there was a significant increase in vertical ground reaction force at the instance of peak knee abduction moment with the wedges. While the laterally wedged insole used in the current study did not alter knee abduction moments as expected, other studies have shown alterations. Future studies should also examine a longer acclimation period, the influence of gait speed, and the effect of different shoe types with the insole.
from #Audiology via ola Kala on Inoreader http://ift.tt/1UJtnBu
via IFTTT
Immediate and One Week Effects of Laterally Wedge Insoles on Gait Biomechanics in Healthy Females
Source:Gait & Posture
Author(s): Joshua T. Weinhandl, Sarah E. Sudheimer, Bonnie L. Van Lunen, Kimberly Stewart, Matthew C. Hoch
It is estimated that approximately 45% of the U.S. population will develop knee osteoarthritis, a disease that creates significant economic burdens in both direct and indirect costs. Laterally wedged insoles have been frequently recommended to reduce knee abduction moments and to manage knee osteoarthritis. However, it remains unknown whether the lateral wedge will reduce knee abduction moments over a prolonged period of time. Thus, the purposes of this study were to 1) examine the immediate effects of a laterally wedged insole in individuals normally aligned knees and 2) determine prolonged effects after the insole was worn for one week. Gait analysis was performed on ten women with and without a laterally wedged insole. After participants wore the wedges for a week, a second gait analysis was performed with and without the insole. The wedged insole did not affect peak knee abduction moment, although there was a significant increase in knee abduction angular impulse after wearing the insoles for one week. Furthermore, there was a significant increase in vertical ground reaction force at the instance of peak knee abduction moment with the wedges. While the laterally wedged insole used in the current study did not alter knee abduction moments as expected, other studies have shown alterations. Future studies should also examine a longer acclimation period, the influence of gait speed, and the effect of different shoe types with the insole.
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1UJtnBu
via IFTTT
Immediate and One Week Effects of Laterally Wedge Insoles on Gait Biomechanics in Healthy Females
Source:Gait & Posture
Author(s): Joshua T. Weinhandl, Sarah E. Sudheimer, Bonnie L. Van Lunen, Kimberly Stewart, Matthew C. Hoch
It is estimated that approximately 45% of the U.S. population will develop knee osteoarthritis, a disease that creates significant economic burdens in both direct and indirect costs. Laterally wedged insoles have been frequently recommended to reduce knee abduction moments and to manage knee osteoarthritis. However, it remains unknown whether the lateral wedge will reduce knee abduction moments over a prolonged period of time. Thus, the purposes of this study were to 1) examine the immediate effects of a laterally wedged insole in individuals normally aligned knees and 2) determine prolonged effects after the insole was worn for one week. Gait analysis was performed on ten women with and without a laterally wedged insole. After participants wore the wedges for a week, a second gait analysis was performed with and without the insole. The wedged insole did not affect peak knee abduction moment, although there was a significant increase in knee abduction angular impulse after wearing the insoles for one week. Furthermore, there was a significant increase in vertical ground reaction force at the instance of peak knee abduction moment with the wedges. While the laterally wedged insole used in the current study did not alter knee abduction moments as expected, other studies have shown alterations. Future studies should also examine a longer acclimation period, the influence of gait speed, and the effect of different shoe types with the insole.
from #Audiology via ola Kala on Inoreader http://ift.tt/1UJtnBu
via IFTTT
Cochlear Implant Access in Six Developed Countries
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1V3bSMk
via IFTTT
Single-sided Deafness Cochlear Implantation: Candidacy, Evaluation, and Outcomes in Children and Adults
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1PgUD5M
via IFTTT
Using the Implant Electrode Array to Conduct Real-time Intraoperative Hearing Monitoring During Pediatric Cochlear Implantation: Preliminary Experiences
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1OrWuY6
via IFTTT
Music Perception of Adolescents Using Electroacoustic Hearing
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1PgUEXa
via IFTTT
Measuring Success: Cost-Effectiveness and Expanding Access to Cochlear Implantation
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1OrWuHE
via IFTTT
A Comprehensive Study on the Etiology of Patients Receiving Cochlear Implantation With Special Emphasis on Genetic Epidemiology
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1RqMYbn
via IFTTT
Outcomes of Adolescents With a Short Electrode Cochlear Implant With Preserved Residual Hearing
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1JUCpe7
via IFTTT
Project ASPIRE: Spoken Language Intervention Curriculum for Parents of Low-socioeconomic Status and Their Deaf and Hard-of-Hearing Children
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1PgUCPd
via IFTTT
The Utility of a Predictive Model for Cochlear Implant Operating Time
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1OrWsQ0
via IFTTT
Bilateral Sequential Cochlear Implantation in Patients With Enlarged Vestibular Aqueduct (EVA) Syndrome
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1PgUDm7
via IFTTT
Long-term Communication Outcomes for Children Receiving Cochlear Implants Younger Than 12 Months: A Multicenter Study
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1ZIlFhp
via IFTTT
Sentence Recognition in Quiet and Noise by Pediatric Cochlear Implant Users: Relationships to Spoken Language
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1RqMX7f
via IFTTT
Method of Speech Stimulus Presentation Impacts Pediatric Speech Recognition: Monitored Live Voice Versus Recorded Speech
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1QhZXer
via IFTTT
Initial Results With Image-guided Cochlear Implant Programming in Children
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1PgUFul
via IFTTT
Language Development in the First Year of Life: What Deaf Children Might Be Missing Before Cochlear Implantation
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1WmQFy2
via IFTTT
Speech Recognition of Bimodal Cochlear Implant Recipients Using a Wireless Audio Streaming Accessory for the Telephone
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1JUCpuD
via IFTTT
Speech Understanding in Children With Normal Hearing: Sound Field Normative Data for BabyBio, BKB-SIN, and QuickSIN
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1PgUFdJ
via IFTTT
Does Bilateral Experience Lead to Improved Spatial Unmasking of Speech in Children Who Use Bilateral Cochlear Implants?
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1RqMVfR
via IFTTT
Beyond Early Intervention: Supporting Children With CIs Through Elementary School
from #Audiology via xlomafota13 on Inoreader http://ift.tt/1QhZVmx
via IFTTT